Australia markets close in 4 hours 11 minutes

Armata Pharmaceuticals, Inc. (ARMP)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
2.5300+0.0200 (+0.80%)
At close: 03:52PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
30,262
33,770
35,017
20,015
14,444
Selling general and administrative
7,850
11,649
7,437
8,281
7,966
Total operating expenses
32,666
40,890
36,946
23,822
21,587
Operating income or loss
-32,666
-40,890
-36,946
-23,822
-21,587
Interest expense
0
2,626
0
64
628
Total other income/expenses net
-25,708
-25,708
-
726
6
Income before tax
-32,650
-69,045
-36,917
-23,155
-22,181
Income from continuing operations
-32,650
-69,045
-36,917
-23,155
-22,181
Net income
-32,650
-69,045
-36,917
-23,155
-22,181
Net income available to common shareholders
-32,650
-69,045
-36,917
-23,155
-22,181
Basic EPS
-1.65
-1.91
-1.08
-0.96
-1.35
Diluted EPS
-1.65
-1.91
-1.08
-0.96
-1.35
Basic average shares
36,066
36,076
34,294
24,104
16,415
Diluted average shares
36,066
36,076
34,294
24,104
16,415